Artificial intelligence (AI) could help biopharmaceutical manufacturers detect contamination in cell cultures sooner than conventional approaches, thereby helping to reduce waste and batch losses. The ...
Although bioprocessors employ cell cultures to develop new treatments for viral infections, viral contamination can stymy any cell culture-based process, including the development of most any ...